XML 21 R8.htm IDEA: XBRL DOCUMENT v3.25.2
BUSINESS, BASIS OF PRESENTATION, AND SIGNIFICANT ACCOUNTING POLICIES
 6 Months Ended
Jun. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BUSINESS, BASIS OF PRESENTATION, AND SIGNIFICANT ACCOUNTING POLICIES BUSINESS, BASIS OF PRESENTATION, AND SIGNIFICANT ACCOUNTING POLICIES
CNO Financial Group, Inc., a Delaware corporation ("CNO"), is a holding company for a group of insurance companies that develop, market and administer health insurance, annuity, individual life insurance and other insurance and financial services products.  The terms "CNO Financial Group, Inc.", "CNO", the "Company", "we", "us", and "our" as used in these financial statements refer to CNO and its subsidiaries.  Such terms, when used to describe insurance business and products, refer to the insurance business and products of CNO's insurance subsidiaries.

We focus on serving middle-income pre-retiree and retired Americans, which we believe are attractive, underserved, high growth markets.  We sell our products through exclusive agents, independent producers (some of whom sell one or more of our product lines exclusively) and direct marketing.

Our unaudited consolidated financial statements reflect normal recurring adjustments that, in the opinion of management, are necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented.  As permitted by rules and regulations of the Securities and Exchange Commission (the "SEC") applicable to quarterly reports on Form 10-Q, we have condensed or omitted certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP").  Results for interim periods are not necessarily indicative of the results that may be expected for a full year.

The December 31, 2024 consolidated balance sheet data was derived from the audited consolidated financial statements included in our 2024 Annual Report on Form 10-K. Accordingly, these interim consolidated financial statements should be read together with the consolidated financial statements included in our 2024 Annual Report on Form 10-K.

When we prepare financial statements in conformity with GAAP, we are required to make estimates and assumptions that significantly affect reported amounts of various assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting periods.  For example, we use significant estimates and assumptions to calculate values for deferred acquisition costs, the present value of future profits, fair value measurements of certain investments (including derivatives), allowance for credit losses and other-than-temporary impairments of investments, assets and liabilities related to income taxes, liabilities for insurance products, liabilities related to litigation, guaranty fund assessment accruals, goodwill and intangible assets, and fee revenue.  If our future experience differs from these estimates and assumptions, our financial statements could be materially affected.

The accompanying financial statements are unaudited and include the accounts of the Company and its subsidiaries. Our consolidated financial statements exclude transactions between us and our consolidated affiliates, or among our consolidated affiliates.
Recently Adopted Accounting Standards

We adopted Accounting Standards Update 2023-07, Segment Reporting (Topic 280): Improvements to Reportable
Segment Disclosures ("ASU 2023-07") effective January 1, 2024. ASU 2023-07 is intended to improve reportable segment
disclosure requirements primarily through enhanced disclosures about significant segment expenses. Such requirements
include: (i) disclosures on significant segment expenses that are regularly provided to the chief operating decision maker
("CODM") and included within each reported measure of segment profit or loss on an annual and interim basis; (ii)
disclosures of an amount for other segment items by reportable segment and a description of its composition on an annual
and interim basis (the other segment items category is the difference between segment revenues less the segment expenses
disclosed pursuant to the new guidance); (iii) providing all annual disclosures on a reportable segment’s profit or loss and
assets currently required by Financial Accounting Standards Board ("FASB") ASC Topic 280, Segment Reporting, in
interim periods; and (iv) specifying the title and position of the CODM and an explanation of how the CODM uses the
reported measures to assess segment performance and make decisions about allocating resources. The adoption of ASU
2023-07 did not have an impact on our financial position or results of operations, and did not have a material impact on our
disclosures. The adoption was made retrospectively.
Recently Issued Accounting Standards

In November 2024, the FASB issued Accounting Standards Update 2024-03, Income Statement—Reporting
Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement
Expenses (“ASU 2024-03”), which requires disclosure of additional information about specific expense categories in the
notes to the financial statements. ASU 2024-03 is effective for annual periods beginning after December 15, 2026 and for
interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. ASU 2024-03 may be
applied retrospectively or prospectively. The adoption of ASU 2024-03 will modify our disclosures but will not have an impact on our financial position or results of operations. We do not expect the impact to our disclosures to be material.

In December 2023, the FASB issued Accounting Standards Update 2023-09, Income Taxes (Topic 740):
Improvements to Income Tax Disclosures ("ASU 2023-09"). ASU 2023-09 is intended to improve the effectiveness of
income tax disclosures by requiring, among other things, the disclosure on an annual basis of: (i) specific categories in the
rate reconciliation; and (ii) additional information for reconciling items that meet a quantitative threshold. In addition, ASU
2023-09 requires disclosure (on an annual basis) of the following information about income taxes paid: (i) the amount of
income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes; and (ii) the amount
of income taxes paid (net of refunds received) disaggregated by individual jurisdictions in which income taxes paid (net of
refunds received) is equal to or greater than 5 percent of total income taxes paid (net of refunds received). ASU 2023-09 is
effective for annual periods beginning January 1, 2025, to be applied prospectively with an option for retrospective
application (with early adoption permitted). The adoption of ASU 2023-09 will modify our disclosures but will not have an
impact on our financial position or results of operations.
Revision of Prior Period Amounts

Certain amounts presented in the prior years’ consolidated statement of operations for the three and six months ended June 30, 2024, consolidated balance sheet as of December 31, 2024, consolidated statement of shareholders’ equity as of December 31, 2024 and related footnotes thereto have been corrected to conform with the current period presentation. During the fourth quarter of 2024, the Company corrected certain immaterial errors that resulted in misclassifications related to market risk benefits.

Upon the adoption of Accounting Standards Update 2018-12, Financial Services—Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts, the Company recorded the fair value of the market risk benefit ("MRB") in policyholder account balances, resulting in no initial MRB presented separately on the consolidated balance sheet. MRBs are required to be presented separately in the consolidated balance sheet. Subsequent to transaction inception, the resulting accumulated change in the fair value of the MRBs was recorded as market risk benefits within the consolidated balance sheet. Additionally, the transaction’s resulting policyholder account balance discount was accreted in change in fair value of MRBs. This accretion should have been recorded in insurance policy benefits within the consolidated statement of operations.

To correct for the error, the Company increased insurance policy benefits and decreased change in value of market benefits by $5.6 million within the consolidated statement of operations for the three months ended June 30, 2024, and the Company increased insurance policy benefits and decreased change in fair value of market risk benefits by $10.8 million within the consolidated statement of operations for the six months ended June 30, 2024.

In addition, the Company identified an immaterial overstatement of its policy holder account balances and insurance policy benefits recorded for the year ended December 31, 2024 and the quarter ended March 31, 2025 related to the calculation of the embedded derivative for its flexible premium bonus indexed annuity product. This error caused the embedded derivative to be overstated as of these periods by $21.6 million and $31.7 million, respectively. The correction of these errors had no impact on our statement of cash flows or segment results for the periods reported.

Finally, the consolidated balance sheet for the year ended December 31, 2024 has been revised to correct immaterial errors related to the classification of non-redeemable preferred stock and to reflect an unsettled investment trade by one of our variable interest entities ("VIEs"). To correct for these errors, fixed maturities, available for sale, at fair value was decreased $110.4 million with a corresponding increase to equity securities at fair value, and investments held by variable interest entities increased $1.5 million with a corresponding increase to other liabilities.
The Company assessed the materiality of these errors on prior period consolidated financial statements and determined that such financial statements were not materially misstated. Accordingly, the Company corrected these immaterial errors in this Quarterly Report on Form 10-Q. The following tables present the impact of the correction of the immaterial errors related to the overstatement of policy holder account balances and insurance policy benefits recorded, the classification of non-redeemable preferred stock and to reflect an unsettled investment trade by one of our variable interest entities for the year ended December 31, 2024 and for the three months ended March 31, 2025 (in millions):

Consolidated Balance Sheet
December 31, 2024
As Previously Reported
Adjustments
As Revised
Investments
  Fixed maturities, available for sale, at fair value
$22,840.5 $(110.4)$22,730.1 
  Equity securities at fair value
162.0 110.4 272.4 
  Investments held by variable interest entities
432.3 1.5 433.8 
Total investments
27,872.1 1.5 27,873.6 
Income tax assets, net
818.9 (4.8)814.1 
Total assets
37,852.6 (3.3)$37,849.3 
Liabilities:
  Policyholder account balances
17,615.8 (21.6)17,594.2 
  Other liabilities
1,161.8 1.5 1,163.3 
Total Liabilities
35,354.2 (20.1)$35,334.1 
Shareholders' equity:
Retained earnings
2,236.3 16.8 2,253.1 
Total shareholders' equity
2,498.4 16.8 2,515.2 
Total liabilities and shareholders' equity
37,852.6 (3.3)37,849.3 

Consolidated Statement of Shareholders' Equity
Retained earnings
Balance, December 31, 2024
$2,236.3 
Correction of immaterial error
16.8 
Balance, December 31, 2024 (as revised)
$2,253.1 
Balance, March 31, 2025
$2,233.6 
Correction of immaterial error
24.6 
Balance, March 31, 2025 (as revised)
$2,258.2 
The following tables present line items for prior period impacts to the Company’s consolidated statement of operations that have been affected by the immaterial error discussed above and that will be revised in conjunction with future filings (in millions):
Three months ended September 30, 2024
As previously reported
Adjustments
As Revised
Insurance policy benefits
$726.2 $4.8 $731.0 
Change in fair value of market risk benefits
(16.1)(4.8)(20.9)
Total benefits and expenses
1,118.6 — 1,118.6 
Income before income taxes
11.0 — 11.0 
Basic earnings per common share
$0.09 $— $0.09 
Diluted earnings per common share
$0.09 $— $0.09 
Nine months ended September 30, 2024
As previously reported
Adjustments
As Revised
Insurance policy benefits
$1,926.4 $15.6 $1,942.0 
Change in fair value of market risk benefits
(30.0)(15.6)(45.6)
Total benefits and expenses
3,044.5 — 3,044.5 
Income before income taxes
307.8 — 307.8 
Basic earnings per common share
$2.22 $— $2.22 
Diluted earnings per common share
$2.18 $— $2.18 
Year ended December 31, 2024
As previously reported
Adjustments
As Revised
Insurance policy benefits
$2,471.9 $(21.6)$2,450.3 
Total benefits and expenses
3,931.2 (21.6)3,909.6 
Income before income taxes
518.3 21.6 539.9 
Income tax expense
114.3 4.8 119.1 
Net income
404.0 16.8 420.8 
Basic earnings per common share
$3.81 $0.15 $3.96 
Diluted earnings per common share
$3.74 $0.15 $3.89 
Three months ended March 31, 2025
As previously reported
Adjustments
As Revised
Insurance policy benefits
$580.1 $(10.1)$570.0 
Total benefits and expenses
986.4 (10.1)976.3 
Income before income taxes
17.7 10.1 27.8 
Income tax expense
4.0 2.3 6.3 
Net income
13.7 7.8 21.5 
Basic earnings per common share
$0.14 $0.07 $0.21 
Diluted earnings per common share
$0.13 $0.08 $0.21